177 related articles for article (PubMed ID: 23185569)
1. Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis.
Sun PH; Ye L; Mason MD; Jiang WG
PLoS One; 2012; 7(11):e50183. PubMed ID: 23185569
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.
Sun PH; Ye L; Mason MD; Jiang WG
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1129-39. PubMed ID: 23552869
[TBL] [Abstract][Full Text] [Related]
3. High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer.
Liu P; Zhang C; Liao Y; Liu J; Huang J; Xia M; Chen M; Tan H; He W; Xu M; Liu T; Ooi S; Du Q; Qin S; Zhu Y; Zou Q; Wang W; Yao S
Cell Death Dis; 2020 Aug; 11(8):687. PubMed ID: 32826853
[TBL] [Abstract][Full Text] [Related]
4. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway.
Cheng X; Chen M; Liu Z
Am J Med Sci; 2020 Jun; 359(6):365-371. PubMed ID: 32498943
[TBL] [Abstract][Full Text] [Related]
6. PPARγ inhibits breast cancer progression by upregulating PTPRF expression.
Xu YY; Liu H; Su L; Xu N; Xu DH; Liu HY; Spaner D; Bed-David Y; Li YJ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9965-9977. PubMed ID: 31799666
[TBL] [Abstract][Full Text] [Related]
7. PTPRM methylation induced by FN1 promotes the development of glioblastoma by activating STAT3 signalling.
Song J; Zhao D; Sun G; Yang J; Lv Z; Jiao B
Pharm Biol; 2021 Dec; 59(1):904-911. PubMed ID: 34225581
[TBL] [Abstract][Full Text] [Related]
8. Receptor-like protein tyrosine phosphatase κ negatively regulates the apoptosis of prostate cancer cells via the JNK pathway.
Sun PH; Ye L; Mason MD; Jiang WG
Int J Oncol; 2013 Nov; 43(5):1560-8. PubMed ID: 24002526
[TBL] [Abstract][Full Text] [Related]
9. Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis.
Li J; Jia L; Zhao P; Jiang Y; Zhong S; Chen D
J Int Med Res; 2012; 40(2):545-55. PubMed ID: 22613415
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration.
Foldynová-Trantírková S; Sekyrová P; Tmejová K; Brumovská E; Bernatík O; Blankenfeldt W; Krejcí P; Kozubík A; Dolezal T; Trantírek L; Bryja V
Breast Cancer Res; 2010; 12(3):R30. PubMed ID: 20507565
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
12. Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.
Cai W; Ye L; Sun J; Mansel RE; Jiang WG
Int J Mol Med; 2010 Apr; 25(4):573-80. PubMed ID: 20198306
[TBL] [Abstract][Full Text] [Related]
13. Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity.
Chaudhary F; Lucito R; Tonks NK
Biochem J; 2015 Jan; 465(1):89-101. PubMed ID: 25287652
[TBL] [Abstract][Full Text] [Related]
14. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
[TBL] [Abstract][Full Text] [Related]
15. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
16. Expression of Semaphorin 3C in Breast Cancer and its Impact on Adhesion and Invasion of Breast Cancer Cells.
Malik MF; Satherley LK; Davies EL; Ye L; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1281-6. PubMed ID: 26977026
[TBL] [Abstract][Full Text] [Related]
17. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer.
Jia Y; Zhou J; Luo X; Chen M; Chen Y; Wang J; Xiong H; Ying X; Hu W; Zhao W; Deng W; Wang L
Cell Signal; 2018 Jan; 42():165-175. PubMed ID: 28988130
[TBL] [Abstract][Full Text] [Related]
18. BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
Naderi A; Liu J; Hughes-Davies L
Mol Cancer; 2010 May; 9():111. PubMed ID: 20482821
[TBL] [Abstract][Full Text] [Related]
19. Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer.
Naderi A; Meyer M
Breast Cancer Res; 2012 Jul; 14(4):R111. PubMed ID: 22817771
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
